Home > Science > SOX10; Clone SOX10 > 991 (Concentrate) Scytek Laboratories Inc

SOX10; Clone SOX10/991 (Concentrate) Scytek Laboratories Inc

Added: (Mon Sep 16 2019)

Pressbox (Press Release) - SOX10; Clone SOX10/991 (Concentrate) Scytek Laboratories Inc
ScyTek Laboratories, Inc. a Utah, USA corporation involved in the manufacture of diagnostic reagents Special Stains, Antibodies, Hematology, Microbiology, Hematoxlyn
Species: Mouse
Immunogen: Recombinant human SOX10 protein fragment (aa115-269) (exact sequence is proprietary).
Clone: SOX10/991
Isotype: IgG2b, Kappa.
Species Reactivity: Human and Mouse. Others-not known.
Positive Control: HepG2 cells, Melanoma, breast carcinomas, gliomas.
Specificity: Recognizes a protein of ~55kDa, identified as SOX10. This antibody does not cross-react with other members of the SOX-family.
https://www.scytek.com/products/90-A00161-C.1-SOX10-Clone-SOX10-991-(Concentrate).asp
--
SOX10, SOX-10, SOX10 antibody, SOX10 stain, SOX10 Melanoma, Melanoma marker, PCWH, SRY (sex determining region Y), box 10, SRY box containing gene 10, SRY related HMG box gene 10, Waardenburg syndrome type 2E(WS2E), WS4, Waardenburg syndrome type 4C (WS4C), A00161
SOX10; Clone SOX10/991 (Ready-To-Use)
ScyTek Laboratories, Inc. a Utah, USA corporation involved in the manufacture of diagnostic reagents Special Stains, Antibodies, Hematology, Microbiology, Hematoxlyn
Species: Mouse
Immunogen: Recombinant human SOX10 protein fragment (aa115-269) (exact sequence is proprietary).
Clone: SOX10/991
Isotype: IgG2b, Kappa.
Species Reactivity: Human and Mouse. Others-not known.
Positive Control: HepG2 cells, Melanoma, breast carcinomas, gliomas.
Specificity: Recognizes a protein of ~55kDa, identified as SOX10. This antibody does not cross-react with other members of the SOX-family.
https://www.scytek.com/products/54-A00161-0002-SOX10-Clone-SOX10-991-(Ready-To-Use).asp

Submitted by:scytek
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.com together with the url of the release.